Uncategorized
Featured Stories
DaVita Names New Leaders to Accelerate Care Transformation
DaVita Inc. to Participate in Fireside Chat with Wolfe Research
DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
-
DaVita Inc. Schedules 1st Quarter 2022 Investor Conference Call
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 5, 2022, at 5 p.m. Eastern Time. The company plans to…
-
DaVita Announces Jason M. Hollar to Join its Board of Directors
DaVita Inc. announced today that its board of directors appointed a new independent director, Jason M. Hollar, to join the board, effective May 6, 2022. Mr. Hollar brings more than 25 years of…
-
New Research Affirms Increase in Access, Equity of COVID-19 Vaccines Administered in Dialysis Centers
Results demonstrate the importance of vaccinating patients at trusted sites of care DENVER and WALTHAM, Mass., April 4, 2022 /PRNewswire/ — A federal partnership established to help increase…
-
DaVita Clinical Research Study Finds Efficacy of Common COVID-19 Vaccines at Parity for Kidney Patients
Dialysis patients who received an adenovirus vector-based COVID-19 vaccine (Johnson & Johnson) were found to have similar rates of breakthrough infection, hospitalization and mortality as dialysis…
-
DaVita Kidney Care Appoints New Chief Medical Officer of Home Modalities
DaVita Kidney Care today announced Dr. Mihran Naljayan as chief medical officer (CMO) of Home Modalities. Dr. Naljayan joined DaVita in 2016 and most recently served as vice president of clinical…